Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Mitochondria-associated membranes (MAMs): A novel therapeutic target for treating metabolic syndrome
Metabolic and genetic analyses of Cpt1a-deficient tumors unveiled metabolic rewiring, with increased glucose import and shunting of glucose-derived pyruvate into the mitochondria to fuel the TCA cycle (Fig
However, even 503B facilities do not produce FDA-approved medications
Warning : Pancreatitis is a serious condition requiring urgent care
US$ 29.69
US$ 24.27
US$ 20.85
US$ 23.80
